Pharmaceuticals

Imperial College London is a hive of activity in drug discovery and development. Imperial hosts some of the world’s leading scientists as well as the affiliation with Imperial NHS trust, one of the largest academic health systems in Europe.

Based on these cutting edge capabilities, ICON has a proven record in assisting pharmaceutical companies and CROs to develop successful, ground-breaking medicines.

Our consultants are key opinion leader physicians and globally renowned researchers, who are committed to translating their expertise into practice in order to push the boundaries of drug development.

We have helped clients solve a range of problems:

 

SCIENTIFIC AND REGULATORY ADVICE AND PROTOCOL ASSISTANCE

Our academics have offered scientific, regulatory advice as well as assistance with clinical trial protocols in all therapeutic classes including rare diseases.`

 

PRE-CLINICAL DEVELOPMENT

Validated disease models in multiple therapeutic areas, high throughput screening, assays, pre-clinical species PK/PD, imaging, medicinal chemistry, structural synthesis pathways and lead optimisation strategy.

 

VACCINE DEVELOPMENT

Identification of antigens, reverse vaccinology, vaccine challenge tests for RSV, malaria and influenza.

 

MOLECULAR DIAGNOSTICS UNIT (MDU)

The CPA-accredited Molecular Diagnostic Unit (MDU) provides fast, accurate diagnostic tests for the management of infectious and genetic diseases using latest technology, including next generation sequencing and UPLC. Through ongoing research and development of new diagnostic methods it strives to remain ahead of the field in diagnostic testing and clinical monitoring.

The MDU supports the HIV and HTLV trials of the Clinical Trials Centre and patient management for The National Centre for Human Retrovirology and Imperial College Healthcare Trust.

Work to date has been centred on HIV, hepatitis viruses and sexually transmitted infections – but the clinical requirements of other clients can be catered for, click for more details

 

 

ACCESS TO FACILITIES

Genomics, biomarker discovery, high throughput mass spec, NMR, X-ray crystallography, advanced PET, advanced MRI, functional MRI and quantitative image analysis using AI.

Whether you need help with pre/clinical development or access to cutting edge validated assays and disease models, we can find the right people to help you solve a problem flexibly and responsively.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research in business, finance, computing, engineering, medicine and science.

Who to contact:

Poh-Choo Pang

Poh-Choo Pang

Engagement Manager

For Clinical Sciences, Medicine, Chemistry, Bio-Sciences, Biochemistry, Bio-tech, Ecology, Microbiology, Physics

Tel: +44 (0)20 7594 6557

Email me

All areas of expertise:

Related Insights

Life after lockdown: Transport

Life after lockdown: Transport

COVID-19 has changed everything. Or has it? How can transport companies, commuters and consumers adjust? Planes, trains and automobiles - best practice, e-mobility and air quality discussed. read more

Robotic revolution

Robotic revolution

Robots are already used to pick and pack online deliveries, vacuum our homes, and to enable surgeons to carry out life-saving operations. In the coming decades, robots have the potential to further enhance human capabilities, providing better care, more efficient transport, and tackling mundane tasks. read more

Mission to the Sun

Mission to the Sun

Understanding the Sun’s moods, and how these influence the solar wind, is the aim of Solar Orbiter, a European Space Agency mission that has Imperial-built kit on board. read more

Related case studies

Scottish health service delivery and performance

Scottish health service delivery and performance

Our consultants shared their expertise in acute medicine and experience of working for governmental organisations and the NHS to help NHS Scotland and the Scottish Government to improve efficiency and quality in the Scottish health service. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Management of pests and vectors of disease

Management of pests and vectors of disease

Helping small-holder farmers with cost-effective techniques to manage pests and vectors of disease, reducing the use of chemical pesticides and promoting the efficiency of natural processes. read more

Latest news

Cricketer set a £1million batting challenge

Cricketer set a £1million batting challenge

A leading cricketer has been offered £1million to strike a ball clear of the Lord’s Pavilion, using a new Mongoose bat tested by Imperial Consultants. read more

Gravity-based energy storage could prove a cheaper option

Gravity-based energy storage could prove a cheaper option

Imperial researchers predict that gravity-fed energy storage systems may provide long-term savings - and analysis suggests that technology from Gravitricity is well suited to provide grid balancing and rapid frequency response services to grid operators. read more

The global energy revolution

The global energy revolution

Dr Iain Staffell, Dr Malte Jansen and consultants from e4Tech commissioned by Drax Group to inform the debate on decarbonising the global energy system, evaluating progress and lessons learnt re fossil fuels, clean power, electric vehicles, carbon capture and storage and efficiency read more